Transitional cell carcinoma is the most common bladder cancer in dogs and while typically not curable, meaningful quality life extension through medical management is achievable for most affected dogs.
TCC welfare management is focused on maintaining comfortable urination for as long as possible. The tumor location at the bladder outlet means the most dangerous welfare event is urinary obstruction - inability to urinate. Urethral stent placement can relieve obstruction and restore urinary comfort in dogs who develop this complication. Most dogs with TCC can be maintained comfortably for months with appropriate treatment. The CADET BRAF test enables earlier diagnosis before extensive symptoms develop, allowing treatment to begin when the tumor is smaller and more responsive.